OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study
Yazan Bader, Reem Suliman, Mohamad Harb, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 5, pp. 1683-1693
Open Access | Times Cited: 7
Yazan Bader, Reem Suliman, Mohamad Harb, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 5, pp. 1683-1693
Open Access | Times Cited: 7
Showing 7 citing articles:
Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany
Armin Scheffler, P Wenzel, Merle Bendig, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Armin Scheffler, P Wenzel, Merle Bendig, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study
Charles E. Argoff, Steven Herzog, Ryan M. Smith, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Charles E. Argoff, Steven Herzog, Ryan M. Smith, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
A real‐world prospective observational study of eptinezumab in Asian patients with migraine
Yi Jing Zhao, Jonathan Ong, Sumit Kumar Sonu, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 7, pp. 810-824
Open Access | Times Cited: 3
Yi Jing Zhao, Jonathan Ong, Sumit Kumar Sonu, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 7, pp. 810-824
Open Access | Times Cited: 3
Migraine and Its Treatment from the Medicinal Chemistry Perspective
Ezgi Pehlivanlar, Simone Carradori, Rahime Şimşek
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 951-966
Open Access | Times Cited: 2
Ezgi Pehlivanlar, Simone Carradori, Rahime Şimşek
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 951-966
Open Access | Times Cited: 2
Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5
Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study
Paul Triller, Virginia N. Blessing, Lucas Hendrik Overeem, et al.
Cephalalgia (2024) Vol. 44, Iss. 10
Closed Access | Times Cited: 1
Paul Triller, Virginia N. Blessing, Lucas Hendrik Overeem, et al.
Cephalalgia (2024) Vol. 44, Iss. 10
Closed Access | Times Cited: 1
Prevalence, Treatment, and Unmet Needs of Migraine in the Middle East: A Systematic Review
Taoufik Alsaadi, Abubaker Al Madani, Mohammed Alhatou, et al.
Pain and Therapy (2024)
Open Access
Taoufik Alsaadi, Abubaker Al Madani, Mohammed Alhatou, et al.
Pain and Therapy (2024)
Open Access
